What does all the recent turmoil mean for the current status and future prospects of the health service? The last 6 months have been exceptionally turbulent. We’ve seen economic turmoil, the sacking and resignation of the chancellor and the prime minister, unprecedented winter pressures in the NHS and public sector strikes. A tornado has whirled through public life. But does spring bring signs that the turbulence is subsiding? And where does that leave the health service? The Health Foundation
Thursday, 6 April 2023
Deaths at home during the Covid-19 pandemic and implications for patients and services
Deaths at home during the Covid-19 pandemic and implications for patients and services There has been a steady increase in the numbers of people dying at home in recent years. These trends became entrenched during the pandemic, which could reflect people fearful of Covid-19 in hospitals and care homes just as much as broader patient preferences for dying at home. So did those dying in their place of residence receive the care they needed, at a good standard? This new research sheds light on the services used by people who died at home in England, before and during the first year of the pandemic. Nuffield Trust
Is Hewitt turning the tide of performance management or swimming against it?
Is Hewitt turning the tide of performance management or swimming against it? Patricia Hewitt’s independent review of integrated care systems (ICSs) is aimed squarely at one of the biggest challenges facing ICSs – the strong culture of top-down performance management in the NHS. The reforms introduced by the 2022 Health and Care Act, with their focus on collaboration across boundaries in local systems, represent a direct challenge to this hierarchical culture, and without a new approach to accountability in the NHS there is little hope of ICSs living up to their original promise. The King's Fund
Understanding the primary care research landscape
Understanding the primary care research landscape Research is a key driver of innovation and improvement. In the NHS it is a vital tool in improving medicines, patient care and pathways, as well as staff wellbeing. The majority of research in the NHS is currently carried out in secondary care, with very little primary care involvement. As a result, the quality of research in the NHS can be restricted in its scope by a smaller patient base and the range of conditions and experiences which present in hospital settings. NHS Confederation
Patients at risk during doctor strike - NHS bosses
Patients at risk during doctor strike - NHS bosses Hospital bosses in England say they cannot guarantee patient safety during next week's four-day strike by junior doctors.
London's Guy's and St Thomas' NHS Trust conceded patients could be harmed as managers struggle to staff rotas.
Other hospital bosses also voiced concerns over the walkout, which will affect both emergency and planned care.
The British Medical Association has refused to exempt any services but says it has plans to protect patients. BBC News
See also:
- 'Concerned doesn't begin to describe it' NHS Providers
- 'Concerned doesn't even begin to describe it': NHS bosses fear carnage from next week's devastating four-day junior doctors' strike The Daily Mail
- Why the next junior doctors' strike will put patients at 'unprecedented' risk The Daily Telegraph
- ‘Disruptive’ strike by NHS junior doctors gives rise to concerns over patient safety The Independent
- Hospital leaders fear for patient safety ahead of 'unprecedented' strike by junior doctors Sky News
Judge says parents and children should receive infected blood payments
Judge says parents and children should receive infected blood payments The parents and children of victims of the contaminated blood scandal should receive government compensation, a judge has said.
The chairman of the infected blood public inquiry, Sir Brian Langstaff, said it was time to "recognise deaths which have so far gone unrecognised".
More than 3,000 people died after contracting HIV or hepatitis C via NHS treatments in the 1970s and 80s.
The government must now respond to the recommendations. BBC News
New tool can spot those most at risk of developing lung cancer, say researchers
New tool can spot those most at risk of developing lung cancer, say researchers Lives could be saved by a new tool that identifies those most at risk of developing lung cancer, according to researchers.
The CanPredict tool can spot those most at risk of developing the disease over the next decade and put them forward for screening tests earlier, researchers from the University of Oxford and the University of Nottingham said. The Independent
See also:
NHS in England to offer pioneering cancer drug to patients with ‘Jolie gene’
NHS in England to offer pioneering cancer drug to patients with ‘Jolie gene’ Health watchdog reverses decision not to recommend olaparib for patients with genetic fault
The NHS in England is to offer thousands of cancer patients the world’s first cancer drug to target an inherited genetic fault, after a U-turn by the health watchdog.
The National Institute for Health and Care Excellence (Nice) opted last year not to recommend olaparib for breast cancer patients with the so-called “Angelina Jolie gene” because of its high cost. The pioneering drug’s list price is £2,317.50 for one pack of 150mg tablets, excluding VAT. The Guardian
See also:
Subscribe to:
Posts (Atom)